Alexion Pharmaceuticals (ALXN) PT Lowered to $190 at Credit Suisse, Following Earnings

February 4, 2021 3:38 PM EST
Get Alerts ALXN Hot Sheet
Price: $167.65 --0%

Rating Summary:
    11 Buy, 26 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 7 | Down: 4 | New: 66
Trade Now! 
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.

Credit Suisse analyst Martin Auster lowered the price target on Alexion Pharmaceuticals (NASDAQ: ALXN) to $190.00 (from $194.00) while maintaining a Neutral rating.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Analyst PT Change

Related Entities

Credit Suisse, Earnings